# AtriCure's New Quality Metric Targets All Sternotomy Patients

> AtriCure's new quality metric could put a clip in nearly every sternotomy.
- Title: AtriCure's New Quality Metric Targets All Sternotomy Patients
- Summary: AtriCure's new quality metric could put a clip in nearly every sternotomy. AtriCure's new quality metric aims to improve surgical outcomes for all open-heart…
- Keywords: atricure, sternotomy, quality metric, open-heart surgery, sts, boxx-noaf, leaaps, q3 revenue, adjusted ebitda, forward ev/ebitda, Seekingalpha
- Source: Seekingalpha — https://seekingalpha.com/article/4964811-atricure-stock-new-quality-metric-could-put-clip-in-nearly-every-sternotomy
- Author: Equity Eagle
- Published: 2026-11-08T05:16:21+00:00
- Read time: 1 min
- Topics: atricure, sternotomy, quality metric, open-heart surgery, sts, boxx-noaf, leaaps, q3 revenue, adjusted ebitda, forward ev/ebitda, money, business
## AtriCure shifts focus
AtriCure is shifting from targeting AF patients to all open-heart surgery patients, aiming for broader adoption as a preventive standard of care.
## Upcoming catalysts
Upcoming catalysts include the STS quality metric rollout in 2027, BoxX-NoAF trial results in spring 2027, and the LeAAPS trial, all supporting institutional adoption.
## Financial performance
ATRC achieved GAAP profitability, with Q3 revenue up 15% year-over-year and adjusted EBITDA up 50.6%, signaling strong operating leverage and healthy cash generation.
## Key takeaway

AtriCure's new quality metric aims to improve surgical outcomes for all open-heart patients by 2027.